MoonLake's psoriatic arthritis drug meets key goals in late-stage trial

MoonLake Immunotherapeutics said on Monday its experimental drug met all main goals in a late-stage trial involving ​adults with an inflammatory disease who had not previously ‌received biologic medic...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。